|
End-of-day quote
NSE India S.E.
11/09/2026
|
5-day change | 1st Jan Change | ||
| 901.75 INR | -1.71% |
|
-0.81% | +19.99% |
| 08-14 | Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-13 | Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 72.58B 757M 656M 619M 562M 1.05B 1.06B 7.39B 2.85B 36.82B 2.84B 2.78B 117B | P/E 2027 * |
30.6x | P/E 2028 * | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 72.58B 757M 656M 619M 562M 1.05B 1.06B 7.39B 2.85B 36.82B 2.84B 2.78B 117B | EV / Sales 2027 * |
7.31x | EV / Sales 2028 * | 5.84x |
| Free-Float |
28.72% | Yield 2027 * |
-
| Yield 2028 * | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUPRIYA | End-of-day quote | |
Bombay S.E.
| SUPRIYA | Delayed |
Last Transcript: Supriya Lifescience Limited
| 1 day | -1.71% | ||
| 1 week | -0.81% | ||
| Current month | +12.96% | ||
| 1 month | +13.91% | ||
| 3 months | -7.72% | ||
| 6 months | +56.31% | ||
| Current year | +19.99% |
| 1 week | 891.25 |  | 933.15 |
| 1 month | 774.3 | | 933.15 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 234.9 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 35 | 01/08/2024 | |
| Chief Executive Officer | 36 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 26/03/2008 | |
| Director/Board Member | 41 | 01/06/2019 | |
| Director/Board Member | 36 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.71% | -0.81% | +39.24% | +208.13% | 757M | |
| +2.02% | -0.96% | +50.69% | +92.40% | 1,015B | |
| +0.28% | -3.24% | +49.57% | +62.65% | 642B | |
| +1.81% | +2.07% | +19.89% | +70.38% | 463B | |
| -0.87% | +2.60% | +38.10% | +37.59% | 353B | |
| +0.02% | +2.13% | +16.92% | +23.76% | 265B | |
| -0.32% | +2.22% | +6.36% | +10.97% | 254B | |
| +1.10% | -12.75% | +38.03% | +45.44% | 206B | |
| -0.20% | -3.77% | -20.87% | -57.84% | 191B | |
| +1.87% | -3.04% | +27.81% | +89.26% | 182B | |
| Average | +0.32% | -3.10% | +26.57% | +58.27% | 357.1B | |
| Weighted average by Cap. | +0.54% | -2.21% | +33.86% | +57.00% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 9.94B 104M 89.82M 84.76M 76.9M 144M 145M 1.01B 390M 5.04B 389M 381M 16.02B | 12.42B 130M 112M 106M 96.11M 180M 182M 1.27B 488M 6.3B 487M 476M 20.03B |
| Net income | 2.37B 24.75M 21.44M 20.24M 18.36M 34.44M 34.69M 242M 93.13M 1.2B 92.95M 90.9M 3.83B | 3.12B 32.57M 28.22M 26.64M 24.16M 45.33M 45.66M 318M 123M 1.58B 122M 120M 5.04B |
| Net Debt | - | - |
Employees
607
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | ₹901.75 | -1.71% | 208,583 |
| 10/09/26 | ₹917.45 | +0.66% | 244,416 |
| 09/09/26 | ₹911.40 | -0.46% | 196,499 |
| 08/09/26 | ₹915.65 | +0.72% | 265,504 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
